Amiodarone 200 mg is a heart rhythm medication used to treat life-threatening ventricular arrhythmias, specifically recurrent ventricular fibrillation and recurrent ventricular tachycardia that causes dangerously low blood pressure. The 200 mg tablet is the standard maintenance dose, taken daily after an initial higher-dose loading period. This is not a first-line medication. It’s reserved for people whose arrhythmias haven’t responded to other treatments or who can’t tolerate alternatives.
What Amiodarone Treats
Amiodarone targets two specific types of dangerous heart rhythms. The first is ventricular fibrillation, where the lower chambers of the heart quiver chaotically instead of pumping blood. The second is hemodynamically unstable ventricular tachycardia, meaning the heart beats so fast from its lower chambers that it can’t push enough blood to the brain and body. Both conditions can be fatal within minutes if untreated.
Doctors also prescribe amiodarone off-label for other rhythm problems, particularly atrial fibrillation, where the upper chambers of the heart beat irregularly. While this isn’t part of the drug’s formal approval, it’s a widespread practice in cardiology.
How It Works in the Heart
Amiodarone belongs to a group called class III antiarrhythmics, but it’s unusual because it affects the heart in multiple ways at once. Its primary long-term effect is slowing the electrical recovery time of heart cells after each beat. This makes it harder for rogue electrical signals to trigger chaotic rhythms.
It also blocks sodium and calcium channels in heart cells, which reduces how excitable those cells are, particularly when the heart is beating fast. This combination of effects is part of why amiodarone works when other rhythm drugs fail. The drug and its active breakdown product accumulate in tissues over weeks and months, which is why it takes a long time to build up to full effect and a long time to leave the body after you stop taking it.
Why the Dose Starts High, Then Drops
Because amiodarone accumulates slowly in body tissues, treatment typically begins with a loading phase of 800 to 1,600 mg per day, split into multiple doses. This phase lasts one to three weeks, depending on how your heart responds. After that, the dose is gradually reduced to a maintenance level, which for most people is 200 mg once daily. Some people need 400 mg daily, but doctors aim for the lowest effective dose to minimize side effects.
Serious Side Effects and Organ Risks
Amiodarone carries a boxed warning from the FDA, the most serious safety alert a medication can have. It flags three major risks: lung damage, liver damage, and the possibility that the drug can actually worsen heart rhythm problems in some cases.
Lung Toxicity
An estimated 1 to 5 percent of people taking amiodarone develop lung toxicity, with higher doses raising the risk. This can show up as inflammation in the lung tissue, causing a new or worsening cough, shortness of breath, or chest pain. In some patient series, lung problems appeared in up to 17 percent of cases, and roughly 10 percent of those were fatal. The tricky part is that routine imaging doesn’t always catch it early, since toxicity can develop rapidly with no warning signs on prior tests. Any new breathing difficulty while on amiodarone warrants immediate medical evaluation.
Liver Toxicity
Amiodarone can damage the liver, sometimes severely. Liver enzyme levels are checked before starting the drug and periodically afterward. If enzymes rise to more than three times the normal level, the dose is typically reduced or the drug is stopped entirely.
Worsening Heart Rhythms
Paradoxically, amiodarone can sometimes make arrhythmias worse. For this reason, treatment is usually started in a hospital or clinical setting where continuous heart monitoring and resuscitation equipment are available.
Thyroid Problems Are Common
Roughly 15 to 20 percent of people on amiodarone develop thyroid dysfunction. This happens because each 200 mg tablet contains a large amount of iodine, and the drug itself interferes with how thyroid hormones work in the body. The effects can go in either direction.
Hypothyroidism (an underactive thyroid) is the more common outcome. In its milder, subclinical form, it may affect up to 26 percent of patients. The overt form, with clearly low thyroid hormone levels, occurs in about 5 percent. Symptoms include fatigue, weight gain, cold sensitivity, and sluggish thinking. This is generally manageable with thyroid hormone replacement.
Hyperthyroidism (an overactive thyroid) is less common but harder to treat. It can cause rapid heart rate, weight loss, tremor, and anxiety. Because the whole point of amiodarone is to control a dangerous heart rhythm, an overactive thyroid speeding the heart back up creates a particularly difficult clinical situation.
What Monitoring Looks Like Long Term
If you’re prescribed amiodarone, expect regular blood work and periodic imaging for as long as you take it. Before starting, you’ll typically have a chest X-ray, lung function tests, thyroid blood tests, and liver enzyme levels drawn. These establish your baseline.
Once on the drug, liver and thyroid function tests are recommended at least every six months. Chest X-rays and a physical exam are repeated every three to six months. Lung function screening has limitations since toxicity can appear suddenly between scheduled tests, so reporting any new cough or breathing changes promptly matters more than the tests themselves.
Eye exams are also part of routine monitoring, as amiodarone causes corneal deposits in most people who take it. These are usually harmless but occasionally affect vision. A smaller number of people develop optic nerve problems, which is more serious.
Skin changes are another long-term effect. Many people become highly sensitive to sunlight, and a small percentage develop a blue-gray skin discoloration, particularly on the face, after years of use. Sunscreen and protective clothing help reduce this risk.
Why Doctors Still Prescribe It
Given the long list of potential harms, you might wonder why amiodarone remains in use. The answer is straightforward: for people with life-threatening ventricular arrhythmias that don’t respond to safer drugs, amiodarone is often the most effective option available. It has a broader range of electrical effects on the heart than any other oral antiarrhythmic, which is precisely why it works when others don’t. The trade-off between its risks and the immediate danger of an untreated fatal arrhythmia is what keeps it as a critical, if carefully managed, part of cardiac care.